Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Clin Cancer Res. 2017 Feb 6;23(14):3552–3556. doi: 10.1158/1078-0432.CCR-16-2064

Table 6. Treatment-Emergent AEs Experienced by ≥20% of Patients (N=34).

Adverse Event Any Graden (%) Grade 3 or 4 n (%)
Stomatitis 23 (68) 7 (21)
Fatigue 19 (56) 0
Hypertriglyceridemia 19 (56) 10 (29)
Nausea 16 (47) 0
Neutropenia 12 (35) 12 (35)
Peripheral edema 11 (32) 2 (6)
Anemia 10 (29) 1 (3)
Skin infection 9 (26) 2 (6)
Cough 8 (24) 0
Diarrhea 8 (24) 2 (6)
Dizziness 8 (24) 1 (3)
Dyspnea 8 (24) 2 (6)
Hypothyroidism 8 (24) 0
Pain in extremity 7 (21) 0